Associate Professor Rebecca Lim

 - Affiliate Investigator

Research focus: Cell and gene therapies including CAR-T, clinical translation of cellular therapies including scalable manufacturing technologies, regulatory compliance and process development

A/Prof Rebecca Lim is a stem cell biologist specialising in gestational tissue derived stem cells. She holds joint appointments with the Department of Obstetrics and Gynaecology, Monash University and The Ritchie Centre, Hudson Institute of Medical Research. A/Prof Lim holds adjunct appointments at the Australian Regenerative Medicine Institute and Chinese University Hong Kong. She serves on the scientific advisory board of the Centre for Commercialisation of Regenerative Medicine – Australia, and is a director of Meluha Capital, a Malaysian-owned biotech company. 

A/Prof Rebecca Lim leads the Amnion Cell Biology team which has been investigating the regenerative potential of human amnion epithelial cells (hAECs). Her research team has uncovered mechanisms through which the hAECs modulate inflammatory events and bolster endogenous repair processes. They have demonstrated that hAECs are able to directly influence the stem cell niche in order to bring about tissue regeneration. This work has now progressed to early phase clinical trials across multiple sites in Australia – in premature babies with bronchopulmonary dysplasia, adults with liver cirrhosis, and stroke.